SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Joe Reich who wrote (21201)4/22/1999 6:26:00 PM
From: DaiS   of 23519
 
Joe, AstraZeneca FYI FWIW

Info from AstraZeneca:

Although the merger has occurred from a legal point of view, from an operational point of view, the integration work has only just begun.
[[This is no big news]]

Despite difficulties engendered by integrative activities, the extant launch plans should be unchanged by the merger. AstraZeneca regard it as being of top priority not to lose momentum in the marketing of Muse.
[[This had been impressed on me before and gives lie to the hypothesis that Astra were lukewarm about Muse or delaying to put pressure on Vivus…….well the support for Muse in the new Astra web site does not look lukewarm to me]]

Launch plans will not be disclosed beforehand.
[[Well maybe I do not have US style persuasive skills!]]

Going forward in time the old Astra (Sweden) should be the preferred source of information about launches/marketing of Muse/Bondil at least for the foreseeable future.
[[I think this stands to reason given that Astra had the muse expertise]]

A gamma minus I know, but I'll keep trying.

DaiS
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext